Summary. In normotensive subjects, acute reduction of mean arterial pressure to from 60 to 75 mm Hg by infusion of sodium nitroprusside caused significant increase in renin activity of renal venous plasma and also in the renalsystemic difference of renin activity. At the same time, the products of the renal-systemic difference of renin activity and renal plasma flow increased significantly, whereas renin substrate activity of plasma was unchanged, indicating that there was an increase in renin release during reduction in pressure. Renin activity of renal venous plasma, expressed in logarithms, showed a significant correlation with the degree of reduction in pressure; an increase in renin activity became significant when mean arterial pressure was reduced to below a level of 70 to 75 mm Hg.
Introduction
Recently, Skinner, McCubbin, and Page (1, 2) showed that reduction in mean renal perfusion pressure causes the kidney to increase renin se-there is any change in this renal mechanism in human hypertensive patients. The present investigation examines the effect of acute reduction of arterial pressure on renin release in normotensive subjects and in patients with renovascular hypertension.
Methods
Clinical material and procedure Studies were performed on hospitalized normotensive and renovascular hypertensive patients on a normal diet. Normotensive patients, four women and nine men ranging in age from 19 to 47 years, showed no evidence of significant cardiovascular disease, and their arterial blood pressures ranged from 111/70 (average mean arterial blood pressure, 84) to 140/83 mm Hg (average mean, 102) at the time of the study. Patients with renovascular hypertension consisted of six women and four men ranging in age from 16 to 53 years, and their arterial pressures ranged from 150/78 (average mean, 102) to 225/151 mm Hg (average mean, 176). Clinical findings are shown in Table I . The diagnosis of renovascular hypertension was established by demonstration of severe stenotic lesions of the main renal artery by aortography and of an ischemic pattern in split renal function studies (Howard or Rapoport test), except in one patient who had segmental ischemia due to severe stenosis of one of the double main renal arteries and showed a negative split function test and another from whom urine was not collected. In six patients, the diagnosis was confirmed later by reduction of arterial pressure after surgical treatment (Table I) . Eight patients had unilateral and one patient bilateral renal arterial stenosis. One patient had severe stenosis on one side and slight stenosis on the other. None showed clinical evidence of heart or renal failure.
The purpose and procedures of the study were explained to all subjects, and their free consent was obtained. All medications except for small amounts of sedatives had been discontinued at least 2 weeks before study, and the patients were fasting and supine at the time of measurements performed in the afternoon. To collect renal venous blood, we introduced a polyethylene catheter (KIFA red-i) into a femoral vein with the patient under local anesthesia and advanced it under fluoroscopic control into a renal vein of normotensive subjects or into the vein of the involved kidney of patients with renovascular hypertension. Position of the catheter was confirmed by observing extraction of p-aminohippurate. In some patients, two catheters were introduced into both femoral veins and passed into the bilateral renal veins at the same time.
Systemic venous blood was collected from a vein of one arm or leg. Brachial arterial blood pressure was measured by auscultation every 2 or 3 minutes along with heart rate, and mean arterial pressure (diastolic plus one-third of pulse pressure) was calculated. To lower systemic arterial pressure, we infused sodium nitroprusside, dissolved in physiologic saline in concentrations of 100 to 150 ,ug per ml, into a vein of one arm or leg at a rate of 30 to 240 ,&g per minute. Sodium nitroprusside is known to exert its depressor effect by direct action on vascular smooth muscle (3) .
Control samples of renal and systemic venous blood were collected from the patients after they had rested at least 30 minutes in the supine position. Thereafter, mean arterial pressure was reduced progressively, by infusion of sodium nitroprusside, from 10 to 37 mm Hg in normotensive subjects and 11 to 55 mm Hg in patients with renovascular hypertension, and repeated samplings of renal and systemic venous blood were made when arterial pressure had been stabilized for 10 to 15 minutes. If symptoms of cerebral ischemia such as yawning appeared, the rate of infusion was decreased until the symptoms disappeared; there were no serious reactions in any subjects tested. In some patients, samplings were repeated when arterial pressure had returned to almost the preinfusion level after termination of the infusion. Assay of plasma renin activity
The procedure used for determination of renin activity of plasma was based on methods of Skinner and associates (1) and Helmer and Judson (4) and on the principle that the sensitivity of renin measurement can be increased by prolonging the time of incubation (5) .
Approximately 8 ml of renal and systemic venous blood was collected simultaneously in polyethylene test tubes and mixed with EDTA(2 X 10' M) to inhibit angiotensinase (6) and with heparin (5 to 10 U per ml blood) as an additional safeguard against coagulation. The tubes were placed in an ice bath, the blood samples were centrifuged at 5,000 rpm for 10 minutes at below 40 C, and the separated plasma was kept frozen. The next morning, each plasma sample was adjusted to pH 5.5 with 0.2 N HCl and divided into three 1-ml portions. One portion was diluted with 0.5 ml of physiologic saline and immediately boiled for 10 minutes. To each of the other two portions was added one drop of 0.5% neomycin sulfate to protect against possible bacterial contamination (7). To one of the two portions we added two drops of 0.1% diisopropyl fluorophosphate (DFP) as a further precaution against angiotensinase, according to Pickens and his co-workers (5). The two portions were then incubated for 24 hours at 370 C without agitation and thereafter diluted with 0.5 ml of saline and boiled for 15 minutes in a chamber with a draft. The supernatant was separated by centrifugation at 5,000 rpm for 10 minutes.
The supernatant samples were assayed for pressor activity in 180-to 300-g male rats treated at least 13 hours before with intraperitoneal sodium pentobarbital (5 mg per 100 g as an initial dose and 1 to 0.5 mg per 100 g as supplemental doses) and pentolinium tartrate (2 mg per 100 g initally and 0.4 mg per 100 g supplementally). Mean (Figure 1 ). Under usual conditions, addition of DFP did not produce significant change in the pressor activity generated in plasma. A series of synthetic angiotensin solutions 1 were injected at frequent intervals and served as standards for measuring pressor activity of the test samples ( Figure 1 ). Pressor activity generated in plasma as a result of 24-hour incubation was determined, expressed in terms of nanograms angiotensin equivalent per milliliter of the original plasma, and designated as plasma renin activity.
Evidence that the substances assayed are renin and angiotensin Incubated renal venous plasma collected during the experimental period demonstrated greater pressor activity than incubated systemic venous plasma (Figure 1 ). Incubated renal and systemic venous plasma showed much greater pressor activity than their unincubated counterparts ( Figure 1 ). The pressor response to incubated plasma was identical to that produced by synthetic angiotensin (Figure 1 ). In control experiments, pressor activity of the supernatant of incubated active plasma was heat stable, was destroyed by incubation with chymotrypsin or trypsin, and disappeared after 24-hour dialysis. The mobility of the pressor substance in the supernatant of incubated plasma on Whatman no. 1 paper chromatography at pH 2.1 was tested; 2 it was similar to that of synthetic angiotensin. To determine the optimal pH in the reaction, we incubated three samples of active plasma (EDTA and DFP added) at 370 C for 24 hours at pH 4.5 to 7.5 and assayed them on the rat. The average pressor activity generated after incubation at pH 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, and 7.5 was 7, 63, 148, 117, 64, 'Valyl-5 octapeptide, Ciba Pharmaceutical Co., Summit, N. J. 2 In collaboration with Dr. Y. Takabatake.
14, and 7 ng per ml, respectively; the activity was greatest at pH 5.5, which is in accord with the results obtained by others (4, 5) .
Examinations of the assay method Effect of heparin. Since heparin used as an anticoagulant might affect angiotensin formation in incubated plasma, its effect was checked. Heparin was added to three samples of active plasma that had been collected without it in concentrations of 0, 5, 10, 20, 40, 100, 200, and 400 U per ml, and the samples were incubated in the presence of EDTA and DFP for 24 hours at pH 5.5. In concentrations below 40 U per ml, addition of heparin did not produce significant change in the pressor activity generated in plasma, and, in concentrations of 100, 200, and 400 U per ml, the average pressor activity decreased to 89, 78, and 64% of the control, respectively. The effect of the doses of heparin used in the present method was considered insignificant.
Angiotensin formation during incubation and renin substrate activity of plasma. Each of four samples of active plasma was incubated for 4, 8, 14, 20 , and 24 hours. Angiotensin produced in plasma was roughly proportional to the length of incubation time when the yield was below 400 ng per ml. In plasma of higher renin activity, the reaction was slowed considerably (Figure 2 ). Since plasma renin activity measured by our method is below 400 ng per ml under usual conditions, renin substrate concentration in the reaction system was usually considered excessive for 24 hours of incubation.
Human renin solution was prepared from cadaver kidneys by the method of Haas and Goldblatt (8) , 3 and renin substrate activity of plasma was assayed in five normotensive subjects and four patients with renovascular hypertension. To 0.5 ml plasma were added 0.2 ml of 0.01 M EDTA, 0.1 ml of diluted human renin solution, and 0.3 ml saline. After pH adjustment to 5.5, 1 drop of 3 In collaboration with Drs. M. Ishii and H. Tagawa. incubation of human renin with human plasma. Possible loss of angiotensin by the remaining angiotensinase in the reaction system was determined by adding human angiotensin in doses of about 10 to 400 ng to 1 ml of plasma and carrying through the complete procedure. In eight experiments, the recovery after a 24-hour incubation ranged from 70 to 92%, mean 83%. Various amounts of human renin were added to 1 ml of human plasma and incubated for 24 hours. The angiotensin yield after incubation was proportional to the amount of renin added when the yield was below 400 ng per ml ( Figure 3) ; the mean recovery was 98 + 9.7 (SD) % in those samples.
Sensitivity and reproducibility. The lower limit of sensitivity of this method varied according to the assay rats. Usually 0.2 to 0.5 ng of standard angiotensin gave a measurable rise, and plasma renin activity of 1 to 2 ng per ml or more was detected.
Renin activity of 50 different plasma samples was measured in duplicate; the average difference between paired measurements was 14.7 ± 10.7 (SD) %o. A difference in renin activity between individual plasma samples was considered significant when it exceeded 14.7 ± 21.3 (2 SD) or 36%o and also 5 ng per ml.
Statistical analyses. In all experiments, the differences between the means were tested by Student's t test (9) .
Results Renin activity in plasma of normotensive subjects and renovascular hypertensive patients during control period. Renin activity of renal venous plasma of 13 normotensive subjects ranged from 4 to 14 ng per ml in the control period, with a mean of 8.1 ± 0.8 (SE); that of systemic venous plasma ranged from 3 to 10 ng per ml, with a mean of 6.4 + 0.6. The difference in renin activity between renal and systemic venous plasma ranged from 0 to 5 ng per ml, mean 1.7 ± 0.5 (Table II) . The normal ranges of renin activity of renal and systemic venous plasma calculated by the present method were considered to be 8.1 + 5.6 (2 SD) and 6.4 + 4.6 (2 SD) ng per ml, respectively.
Renin activity of venous plasma from the involved kidneys of 10 renovascular hypertensive patients (Table IV) Effect of reduction of arterial pressure on renin activity in plasma of normotensive subjects. After control samplings of renal and systemic venous blood were made, graded doses of sodium nitroprusside were infused into 13 normotensive subjects. Mean arterial pressure was reduced progressively by from 10 to 37 mm Hg in 1 to 3 steps, and samplings were repeated during each hypotensive period. Reduction of mean arterial pressure to 60 to 75 mm Hg caused significant increase of renin activity in renal venous plasma in 8 subjects and no significant change in 5; above 75 mm Hg, no subjects showed significant change in renin activity. Table II shows the results obtained during reduction in pressure to 60 to 75 mm Hg in 13 subjects, and Figure 4 illustrates a typical example of the response to reduction in pressure. On the average, renin activity of renal venous plasma increased from 8.1 to 37.5 ng per ml when arterial pressure decreased from 93 to 68 mm Hg; the increase was significant (p < 0.01). plasma was accompanied by one in systemic venous plasma, which was significant but less in magnitude. The renal-systemic difference in renin activity increased in 6 of the 13 subjects; the mean difference increased from 1.7 to 20.1 ng per ml (p < 0.05, Table II ). The increase in renal venous renin activity was detected after 10 to 15 minutes of reduction in mean arterial pressure to below 75 mm Hg. It persisted for the hypotensive period and then returned almost to the control value 15 to 30 minutes after arterial pressure recovered to near the preinfusion level (Figure 4) . The return of systemic venous renin activity was delayed compared to that of renal venous renin activity. In control observations, renin activity was measured several times without reduction in pressure, and there, were no significant changes between measurements.
In three normotensive subjects, renal venous blood was collected from both kidneys simultaneously. There was no significant difference in renin activity between them, either in the control or hypotensive periods.
Effect of reduction of arterial pressure on renin substrate activity of plasma and on renal plasma flow in normotensive subjects. In five subjects, renin substrate activity of renal venous plasma was measured at the same time, using human renin solution. The plasma substrate activity was 623 ± 61 (SE) ng per ml in the control period and 614 + 65 in the hypotensive period; there was no significant change during reduction in pressure.
In four subjects, total renal plasma flow (RPF) was measured simultaneously by the Fick principle, using p-aminohippurate. When average mean arterial pressure was reduced from 93 to 65 mm Hg, RPF decreased from 653 ± 66 (SE) to 500 ± 82 ml per minute, and renal-systemic difference of renin activity (A RA) increased from 2.8 + 1.0 to 24.5 ± 7.8 ng per ml (Table III) . A RA x RPF was then calculated as an index of the amount of renin released from the kidney. It increased from 1.64 ± 0.59 (SE) to 10.38 + 3.06 jug per minute during the hypotensive period; the increase was significant (p < 0.05, Table III) .
Correlation between renin activity of renal venous plasma and mean arterial pressure level during reduction in pressure. Renin activity of renal by 20%. There was also a significant reciprocal correlation (r = -0.65, p < 0.001) between renin activity in logarithms and the level of mean arterial pressure during the hypotensive period, as shown in Figure 5 ; an increase in renin activity became significant when mean arterial pressure was reduced to below a level of 70 to 75 mm Hg. In the control period, however, renin activity showed little correlation with mean arterial pressure levels. There were no correlations between renin activity and pulse pressure in the control or hypotensive periods. Effect of reduction of arterial pressure on renin activity in plasma from the involved kidneys of renovascular hypertensive patients. Reduction of mean arterial pressure by from 11 to 55 mm Hg by sodium nitroprusside infusion caused significant increase of renin activity in plasma from the involved kidneys in all renovascular hypertensive patients tested, and there was a marked increase in the renal-systemic difference (Table IV) . Figure 6 illustrates an example. On the average, in 10 patients, renin activity of renal and systemic venous plasmas increased from 40.4 to 171 (p < 0.005) and 21.7 to 69.6 ng per ml (p < 0.025), respectively, and the renal-systemic difference increased from 18.7 to 101 ng per ml (p < 0.005, Table IV ). In 4 of the 10 patients, renin substrate activity of plasma from the involved kidney was measured at the same time. The plasma substrate activity was 610 ± 26 (SE) ng per ml in the control period and 590 ± 34 during reduction in pressure; there was no significant change.
In renovascular hypertensive patients, levels of (Table IV) . Six of the 7 patients had unilateral renal arterial stenosis. When mean renal-systemic difference in renin activity inarterial pressure was reduced to 90 to 99 mm Hg, creased at 103 mm Hg in plasma from the left renin activity of plasma from the uninvolved kid-side and at 95 mm Hg in that from the right side. ney was not significantly different or less compared to that of systemic venous plasma. There Discussion was no significant change in the average renalThe results of the examinations of the assay systemic difference of renin activity, whereas method and the characteristics of the pressor mathere was a marked increase in that in the in-terial assayed seem to prove the validity of the volved kidney (Table IV) . Figure 7 illustrates present method for measurement of renin activity.
an example of the assay of renin activity of plasma Although the method does not measure the absofrom both kidneys in one patient with renovascu-lute concentration of renin in plasma, and other lar hypertension. Furthermore, the average renal-plasma constituents, including renin substrate systemic difference during reduction in pressure (5), could affect renin activity measured by this was significantly (p < 0.05) less in the uninvolved method, it was useful for the purpose of the preskidney (-4.7 + 4.8 ng per ml, Table IV) than ent study. Page, Dustan, and Bumpus (10) that in the normotensive subjects (20.1 ± 7.4 ng state that the comparison of renal venous with per ml, Table II). One patient had severe steno-systemic plasma after incubation has proved resis of the left main renal artery and slight stenosis liable for comparable experimental purposes. of the right artery. When pressure was reduced,
The results obtained in normotensive subjects are consistent with the observations of Skinner and associates in dogs (1) . Acute reduction of arterial pressure caused significant increase in renin activity of renal venous plasma and in the renal-systemic difference of renin activity. Since there was no significant change in renin substrate activity of plasma measured at the same time, and since it has been reported that there is little difference in renin activity between systemic arterial and venous plasma (11) , the products of the renal-systemic difference of renin activity and RPF were assumed to represent indexes of the amount of renin released from the kidney, although the products may give a minimal estimate of the true renal secretion of renin, since it has been known that renin leaks out also in the renal lymphatics (12) and urine (13) . There was a significant increase in the calculated products parallel to inincrease in renin activity. Accordingly, marked increase in renin activity of renal venous plasma or in the renal-systemic difference of renin activity during reduction in pressure appears to indicate an increase in renin secretion from the kidney. The results suggest that the human kidney acts as a baroreceptor, in the sense that it can respond to change in arterial pressure by altering the rate of renin secretion; they support the view that this function of the kidney controlling renin secretion could be a homeostatic mechanism which participates in control of normal arterial pressure (1) . This sensing mechanism seems capable of responding to reduction in pressure in a quantitative manner; renin activity of renal venous plasma, expressed in logarithms, showed a significant correlation with the degree of reduction in pressure and also with the level of mean arterial pressure. An increase in renin release became significant when mean arterial pressure was reduced to below a level of 70 to 75 mm Hg, whereas, above 75 mm Hg, there was no significant change. The findings suggest a threshold for increased secretion of renin at a mean arterial pressure level of 70 to 75 mm Hg in normotensive subjects.
The present study does not clarify what final mechanism initiates increased secretion of renin when arterial pressure decreases, but there are at least three possibilities. 1) Decrease in mean renal perfusion pressure may directly stimulate the juxtaglomerular cells acting as baroreceptors (14, 1) . A significant correlation between renin activity of renal venous plasma and the degree of reduction in pressure might support this theory, but there was no evidence which suggested that reduction in pressure acted directly. 2) Decrease in tubular sodium concentration or other change in tubular fluid caused by decrease in renal blood flow and glomerular filtration rate due to reduction in pressure may stimulate the macula densa and the juxtaglomerular cells (15) .
3) Increased sympathetic discharge caused reflexly by reduction in pressure may exert a direct effect on the juxtaglomerular cells or an indirect effect on renal hemodynamics, resulting in increased secretion of renin. Stimulation of the renal nerve has been shown to cause increased release of renin in dogs (16) . Increased sympathetic discharge during reduction in pressure was apparent from an increase in heart rate (17); the average heart rate increased from 75 to 96 beats per minute during the hypotensive period (Table II) . On the other hand, a threshold of 70 to 75 mm Hg demonstrated in normotensive subjects is near the level under which renal autoregulation is known to fail, and this failure might be associated with an increased secretion of renin.
The differences in response between the kidneys of normotensive subjects and the involved kidneys of renovascular hypertensive patients were striking. In renovascular hypertensive patients, significant increase in renin activity of renal venous plasma and the renal-systemic difference of renin activity occurred in the involved kidney at mean arterial pressures ranging from 90 to 137 mm Hg. Although blood flow of the involved kidney was not measured, marked increase in the renal-systemic difference appears to indicate an increase in renin release from the involved kidney, since there was concomitantly a marked increase in renin activity in systemic plasma in 9 of the 10 patients (Table IV) and there was no significant change in renin substrate activity of plasma. The findings, then, suggest that the threshold of arterial pressure for increased renin release in the involved kidney was shifted to a range much higher than in normotensive subjects. Also, the magnitude of renin release from the involved kidney was significantly greater compared to that in normotensive subjects, whereas the decrement in pressure or the degree of reduction in pressure in terms of A MAP/MAP was not significantly different. In one patient -(A.U.), the magnitude of renin release was considerably less than in other patients (Table IV) ; this might have been associated with the segmental ischemia of this patient's kidney (Table I) .
The finding that, in the involved kidneys of renovascular hypertensive patients, the mechanism controlling renin secretion operates at much higher systemic arterial pressure levels with more enhanced responsiveness than in normotensive subjects appears to suggest that the renin-angiotensin system participates in maintaining high arterial pressure in this disease. The altered response of the involved kidney could tend to oppose a fall of systemic arterial pressure to normotensive levels. However, the participation of the reninangiotensin system in this disease is not due to its direct vasoconstrictor action alone. Circulating renin levels in renovascular hypertensive patients have been reported to be variable (18) (19) (20) and were unrelated to levels of arterial pressure; renin activity of systemic venous plasma was in the normal range in three patients, whereas arterial pressures measured at the same time were hypertensive (Table IV) .
The upward shift of the threshold of systemic arterial pressure at which renin release increased in renovascular hypertension does not imply resetting of the sensitivity of the renal mechanism that controls release, since renal perfusion pressure beyond the renal arterial stenosis could be much lower than systemic arterial pressure (21) , and the renal arterial pressure sensed by the mechanism could be the pressure level at which renin release normally increases. Skinner and co-workers (2) found, in dogs made hypertensive by constriction of a renal artery, that renin release occurred at elevated systemic arterial pressure, but actual renal perfusion pressure beyond the constriction was in the same range as in normal dogs. The enhanced responsiveness of the involved kidney might also be explained by the pressure drop across the stenosis of the renal artery. The magnitude of renin secretion was shown to be correlated with the degree of reduction in pressure, and Figure 5 shows, at lower pressure levels, reduction in pressure of the same degree could cause secretion of more renin than at higher pressure levels.
The involved kidney, even when renin activity in the control period was normal, could cause significant increase in renin release at higher than normal pressure when arterial pressure was reduced. The finding that the effect of pressure reduction was unrelated to renin activity in the control period suggests that it may be preferable, for diagnosis of renovascular hypertension, to measure the threshold at which there is an increase in renin activity.
In the contralateral uninvolved kidneys of renovascular hypertensive patients, no significant release of renin was detected in the control or hypotensive periods; the renal-systemic difference of renin activity during reduction in pressure was significantly less, even when compared to that in normotensive subjects.
The mechanism of the different response of the uninvolved kidney was not known, but three possibilities exist. 1) 
